| Followers | 0 |
| Posts | 48 |
| Boards Moderated | 0 |
| Alias Born | 06/06/2022 |
Thursday, March 23, 2023 1:57:34 PM
Hmm yet mf said he was going to turkey. Enrolment would be starting mid February 2022. And yet he backtracked on that as well. If it was so cheap why wouldn’t he have started that trial and got the remaining patients he needed? Stupidity or ignorance? Probably both.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
